Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7254139 | 0.91 | HPGD (0.31) | HPGDLMNAHTTSMN1; SMN2MAPT | |
| SCHEMBL7248382 | 0.81 | NR3C1 (0.41) | HPGDLMNAHTTSMN1; SMN2PDE10A | |
| SCHEMBL7254649 | 0.77 | — | — | |
| SCHEMBL7097637 | 0.76 | BRD4 (0.32) | HPGDLMNAHTTPDE10A | |
| SCHEMBL7102580 | 0.76 | HPGD (0.40) | HPGDLMNAHTTSMN1; SMN2MAPT | |
| SCHEMBL7248262 | 0.76 | MEN1 (0.32) | — | |
| SCHEMBL7248995 | 0.74 | BRD4 (0.40) | HPGDLMNAHTTSMN1; SMN2PDE10A | |
| SCHEMBL7248295 | 0.74 | PGR (0.37) | HPGDLMNAHTTSMN1; SMN2MAPT | |
| SCHEMBL7248476 | 0.74 | BRAF (0.34) | HPGDLMNAHTTPDE10A | |
| SCHEMBL7103450 | 0.74 | BRD4 (0.31) | HTTPDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6503935-B1 | Treating urinary incontinence or retrograde ejaculation | ABBOTT LABORATORIES | 2003-01-07 | — | — | US | disclosed |